ALX-0171 Phase I Pharmacokinetic Study in Healthy Male Volunteers
NCT01875926
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
44
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
RSV Infection
Interventions
BIOLOGICAL:
ALX-0171
BIOLOGICAL:
ALX-0171
BIOLOGICAL:
ALX-0171
Sponsor
Ablynx, a Sanofi company